Gain Therapeutics, Inc.
GANX
$1.65
-$0.04-2.37%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 136.59% | 31.57% | -26.20% | -12.67% | -13.81% |
| Total Receivables | 1.79% | -44.24% | 59.51% | 15.77% | 104.92% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -35.22% | -23.12% | 0.30% | 164.96% | -65.79% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 111.43% | 13.01% | -16.54% | -3.89% | -15.56% |
|
|
|||||
| Total Current Assets | 111.43% | 13.01% | -16.54% | -3.89% | -15.56% |
| Net Property, Plant & Equipment | 51.48% | -18.03% | 17.14% | -13.02% | -19.42% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -10.30% | -10.40% | 1.27% | -5.96% | -14.08% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 0.29% | -0.29% | 7.36% | 2.19% | -4.63% |
| Total Assets | 107.98% | 11.57% | -15.40% | -4.12% | -15.61% |
|
|
|||||
| Total Accounts Payable | -47.69% | -41.87% | 26.10% | 127.35% | -13.86% |
| Total Accrued Expenses | -1.35% | 5.55% | -8.65% | -1.81% | -1.90% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -8.61% | -7.96% | 0.23% | -3.43% | -8.75% |
| Total Finance Division Other Current Liabilities | -25.17% | 20.25% | -79.69% | -12.89% | -62.87% |
| Total Other Current Liabilities | -25.17% | 20.25% | -79.69% | -12.89% | -62.87% |
| Total Current Liabilities | -19.62% | -19.75% | 3.35% | 28.56% | -14.88% |
|
|
|||||
| Total Current Liabilities | -19.62% | -19.75% | 3.35% | 28.56% | -14.88% |
| Long-Term Debt | 0.44% | -8.17% | 3.47% | -4.20% | -12.71% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 224.92% | -30.03% | 203.59% | -42.91% | -44.28% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -26.01% | 0.98% | 11.00% | -4.11% | 26.21% |
| Total Liabilities | -15.96% | -17.52% | 5.02% | 22.16% | -12.32% |
|
|
|||||
| Common Stock & APIC | 16.62% | 7.94% | 3.30% | 3.20% | 3.12% |
| Retained Earnings | -4.69% | -5.77% | -6.78% | -5.58% | -4.87% |
| Treasury Stock & Other | 37.94% | -3.58% | 587.16% | 51.56% | -201.94% |
| Total Common Equity | 214.16% | 59.88% | -36.05% | -21.25% | -17.62% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 214.16% | 59.88% | -36.05% | -21.25% | -17.62% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 214.16% | 59.88% | -36.05% | -21.25% | -17.62% |
|
|
|||||